<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CD8+ T cells &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/cd8-t-cells/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 19 Jan 2026 11:59:42 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>CD8+ T cells &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Targeting Thymidylate Synthase Boosts Cervical Cancer Immunity</title>
		<link>https://bioengineer.org/targeting-thymidylate-synthase-boosts-cervical-cancer-immunity/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 19 Jan 2026 11:59:17 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[CD8 T cell infiltration]]></category>
		<category><![CDATA[CD8+ T cells]]></category>
		<category><![CDATA[cervical cancer immunotherapy]]></category>
		<category><![CDATA[İçeriğe göre en uygun 5 etiket: **Thymidylate synthase]]></category>
		<category><![CDATA[Metabolic reprogramming** * **Thymidylate synthase:** Araştırmanın temel hedefi ve ana konusu. * **Cervical cancer immunotherapy:** Çalışmanın odaklandığı spesifik kanser türü ve geliştirilmeye ç]]></category>
		<category><![CDATA[Metabolic-Immune Crosstalk]]></category>
		<category><![CDATA[Thymidylate Synthase Inhibition]]></category>
		<category><![CDATA[tumor microenvironment]]></category>
		<category><![CDATA[Tumor microenvironment modulation]]></category>
		<guid isPermaLink="false">https://bioengineer.org/targeting-thymidylate-synthase-boosts-cervical-cancer-immunity/</guid>

					<description><![CDATA[In a groundbreaking study that could dramatically shift the landscape of cervical cancer treatment, researchers have unveiled a promising new therapeutic strategy centered around targeting thymidylate synthase (TS). This pivotal enzyme, essential for DNA synthesis and cell proliferation, has now been linked to the modulation of immune responses within the tumor microenvironment, revealing a compelling [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">318296</post-id>	</item>
		<item>
		<title>Aging Fibroblasts Impair CD8+ T Cells in Cancer</title>
		<link>https://bioengineer.org/aging-fibroblasts-impair-cd8-t-cells-in-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 15 Jan 2026 02:59:25 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[CD36]]></category>
		<category><![CDATA[CD36 receptor]]></category>
		<category><![CDATA[CD8+ T cell dysfunction]]></category>
		<category><![CDATA[CD8+ T cells]]></category>
		<category><![CDATA[Colorectal cancer]]></category>
		<category><![CDATA[Lipid peroxidation]]></category>
		<category><![CDATA[Makale içeriğine göre en uygun 5 etiket: **Senescent fibroblasts]]></category>
		<category><![CDATA[Makale içeriğine ve anahtar kelimelere göre en uygun 5 etiket: **Senescent Fibroblasts]]></category>
		<category><![CDATA[T cell Dysfunction** **Açıklama:** 1. **Senescent Fibroblasts:** Çalışmanın temel odağı olan hücre tipi. 2. **CD8+ T Cells:** Etkilenen ve i]]></category>
		<category><![CDATA[Tumor microenvironment** **Açıklama:** 1. **Senescent fibroblasts:** Makalenin ana konusu ve CD8+ T hücre disfonksiyonundan sorumlu tutulan hücre tipi. 2. **CD8+ T cell dysfunction:** Mak]]></category>
		<guid isPermaLink="false">https://bioengineer.org/aging-fibroblasts-impair-cd8-t-cells-in-cancer/</guid>

					<description><![CDATA[In an extraordinary study destined to reshape our understanding of tumor immunology, researchers have unveiled the mechanisms by which senescent fibroblasts exert influence over CD8+ T cell dysfunction in the context of colorectal cancer. The findings, published in the Journal of Translational Medicine, could pave the way for novel therapeutic strategies aimed at rejuvenating the [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">317042</post-id>	</item>
		<item>
		<title>M2 Macrophages Shape CD8+ T Cell Response in NSCLC</title>
		<link>https://bioengineer.org/m2-macrophages-shape-cd8-t-cell-response-in-nsclc/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 07 Jan 2026 08:07:47 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[CD8+ T cells]]></category>
		<category><![CDATA[immunotherapy]]></category>
		<category><![CDATA[M2 macrophages]]></category>
		<category><![CDATA[NSCLC]]></category>
		<category><![CDATA[SPP1-CD44 pathway]]></category>
		<guid isPermaLink="false">https://bioengineer.org/m2-macrophages-shape-cd8-t-cell-response-in-nsclc/</guid>

					<description><![CDATA[Recent advancements in cancer immunotherapy have highlighted the crucial role of tumor microenvironment components, particularly M2 macrophages, in shaping the immune response against malignancies. A groundbreaking study published in the Journal of Translational Medicine by Zhang et al. delves deep into the sophisticated mechanisms through which M2 macrophages influence the behavior of CD8+ CD101-TIM3+ T [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">314358</post-id>	</item>
		<item>
		<title>Dietary Restriction Boosts CD8+ T Cell Cancer Immunity</title>
		<link>https://bioengineer.org/dietary-restriction-boosts-cd8-t-cell-cancer-immunity/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 10 Dec 2025 21:41:54 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Cancer immunotherapy]]></category>
		<category><![CDATA[CD8+ T cells]]></category>
		<category><![CDATA[Makalenin içeriğine ve ana temalarına göre en uygun 5 etiket: **Dietary Restriction]]></category>
		<category><![CDATA[Metabolic Reprogramming]]></category>
		<category><![CDATA[Tumor Immunity** **Açıklama:** 1. **Dietary Restriction:** Makalenin ana konusu ve müdahale yöntemi. 2. **CD8+ T Cells:** Araştırmanın odaklandığı]]></category>
		<guid isPermaLink="false">https://bioengineer.org/dietary-restriction-boosts-cd8-t-cell-cancer-immunity/</guid>

					<description><![CDATA[In a groundbreaking study that bridges nutrition, immunology, and oncology, researchers have unveiled compelling evidence that dietary restriction can fundamentally reprogram the fate of CD8+ T cells, thereby enhancing anti-tumor immunity and bolstering responses to immunotherapy. This discovery, published in Nature Metabolism, promises to reshape current paradigms surrounding cancer treatment and immune system modulation, offering [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">305217</post-id>	</item>
		<item>
		<title>SOAT1 Modulates CD8+ T Cell Immune Response in Ovarian Cancer</title>
		<link>https://bioengineer.org/soat1-modulates-cd8-t-cell-immune-response-in-ovarian-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 20 Nov 2025 15:14:44 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Cancer immunotherapy]]></category>
		<category><![CDATA[CD8+ T cells]]></category>
		<category><![CDATA[lipid metabolism]]></category>
		<category><![CDATA[Ovarian cancer]]></category>
		<category><![CDATA[SOAT1]]></category>
		<guid isPermaLink="false">https://bioengineer.org/soat1-modulates-cd8-t-cell-immune-response-in-ovarian-cancer/</guid>

					<description><![CDATA[In the relentless pursuit of understanding cancer biology, researchers continually strive to unlock the immune response mechanisms that shape tumor immunity. A recent study titled “SOAT1 in ovarian cancer cells regulates immune response mediated by CD8+ T cells,” authored by He, J., Siu, M.K., Long, R., et al., delves into the intricate relationship between lipid [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">299185</post-id>	</item>
		<item>
		<title>Craters on Melanoma Cell Surfaces Identified as Key Sites for Tumor Destruction</title>
		<link>https://bioengineer.org/craters-on-melanoma-cell-surfaces-identified-as-key-sites-for-tumor-destruction/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 17 Oct 2025 15:16:03 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[CD8+ T cell engagement]]></category>
		<category><![CDATA[CD8+ T cells]]></category>
		<category><![CDATA[CRATER tumor niches]]></category>
		<category><![CDATA[CRATERs]]></category>
		<category><![CDATA[Immunotherapy biomarkers]]></category>
		<category><![CDATA[tumor microenvironment]]></category>
		<category><![CDATA[Zebrafish melanoma model]]></category>
		<guid isPermaLink="false">https://bioengineer.org/craters-on-melanoma-cell-surfaces-identified-as-key-sites-for-tumor-destruction/</guid>

					<description><![CDATA[Recent groundbreaking research published in the prestigious journal Cell reveals a fascinating and previously uncharted feature on the surface of melanoma cells: immune “craters.” These crater-like structures serve as specialized hubs that significantly enhance the engagement between tumor cells and CD8+ T cells, a critical component of the immune system’s arsenal against cancer. This discovery [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">282873</post-id>	</item>
	</channel>
</rss>
